Role of micro-RNA in colorectal cancer screening;Papel de los micro-RNA en el cribado del cáncer colorrectal

Cirugia Espanola

Volumn 92, Issue 10, 2014, Pages 654-658

  Rodríguez Montes, José Antonio ^a   Menéndez Sánchez, Pablo ^b  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b Hospital Gutierrez Ortega   (Spain)

Author keywords

Cancer; Colon; Diagnosis; Micro RNA; Screening

Indexed keywords

MICRORNA; TUMOR MARKER;

COLORECTAL NEOPLASMS; EARLY CANCER DIAGNOSIS; GENETICS; HUMAN; PROCEDURES;

BIOMARKERS, TUMOR; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; HUMANS; MICRORNAS;

EID: 84910016702     PISSN: 0009739X     EISSN: 1578147X     Source Type: Journal    
DOI: 10.1016/j.ciresp.2014.05.012     Document Type: Article

References (28)

1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Disponible en: http://globocan.iarc.fr, accedido 19/02/2014.
2. SEER Cancer Statistics Factsheets: Colon and rectum cancer. National Cancer Institute. Bethesda, MD. [accedido 24 Feb 2014]. Disponible en: . http://seer.cancer.gov/statfacts/html/colorect.html.
3. Menéndez P., Villarejo P., Padilla D., Menéndez J.M., Rodríguez Montes J.A. Epigenética y cáncer colorrectal. Cir Esp 2012, 90:277-283.
4. Duffy M.J. Role of tumor markers in patients with solid cancers: A critical review. Eur J Intern Med 2007, 18:175-184.
5. Yamashita K., Watanabe M. Clinical significance of tumor markers and an emerging perspective on colorectal cancer. Cancer Sci 2009, 100:195-199.
6. Duffy M.J. Evidence for the clinical use of tumour markers. Ann Clin Biochem 2004, 41:370-377.
7. Sturgeon C.M., Duffy M.J., Stenman U.H., Lilja H., Brünner N., Chan D.W., et al. National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers. Clin Chem 2008, 54:e11-e79.
8. Locker G.Y., Hamilton S., Harris J., Jessup J.M., Kemeny N., Macdonald J.S., et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 2006, 24:5313-5327.
9. Duffy M.J., van Dalen A., Haglund C., Hansson L., Holinski-Feder E., Klapdor R., et al. Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur J Cancer 2007, 43:1348-1360.
10. Altomare D.F., di Lena M., Giuratrabocchetta S. MicroRNA: Future perspectives in colorectal cancer. Colorectal Dis 2012, 14:133-134.
11. Link A., Balaguer F., Shen Y., Nagasaka T., Lozano J.J., Boland C.R., et al. Fecal micro-RNA as novel biomarkers for colon cancer screening. Cancer Epidemiol Biomarkers Prev 2010, 19:1766-1774.
12. Kalimutho M., di Cecilia S., del Vecchio Blanco G., Roviello F., Sileri P., Cretella M., et al. Epigenetically silenced miR-34bc as a novel faecal-based screening marker for colorectal cancer. Br J Cancer 2011, 104:1770-1778.
13. Dong Y., Wu W.K., Wu C.W., Sung J.J., Yu J., Ng S.S. MicroRNA dysregulation in colorectal cancer: A clinical perspective. Br J Cancer 2011, 104:893-898.
14. Koga Y., Yasunaga M., Takahashi A., Kuroda J., Moriya Y., Akasu T., et al. MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening. Cancer Prev Res (Phila) 2010, 3:1435-1442.
15. Wang X., Kuang Y.Y., Hu X.T. Advances in epigenetic biomarker research in colorectal cancer. World J Gastroenterol 2014, 20:4276-4287.
16. Mazeh H., Mizrahi I., Ilyayev N., Halle D., Brücher B., Bilchik A., et al. The diagnostic and prognostic role of microRNA in colorectal cancer: A comprehensive review. J Cancer 2013, 4:281-295.
17. Nugent M., Miller N., Kerin M.J. MicroRNAs in colorectal cancer: Function, dysregulation and potential as novel biomarkers. Eur J Surg Oncol 2011, 37:649-654.
18. Ferracin M., Veronese A., Negrini M. Micromarkers: miRNAs in cancer diagnosis and prognosis. Expert Rev Mol Diagn. 2010, 10:297-308.
19. Menéndez P., Villarejo P., Padilla D., Menéndez J.M., Rodríguez-Montes J.A. Implications of the histological determination of micro-RNA in the screening, diagnosis and prognosis of colorectal cancer. J Surg Oncol 2013, 108:70-73.
20. Menéndez P., Padilla D., Villarejo P., Palomino T., Nieto P., Menéndez J.M., et al. Prognostic implications of serum microRNA-21 in colorectal cancer. J Surg Oncol 2013, 108:369-373.
21. Chen X., Ba Y., Ma L., Cai X., Yin Y., Wang K., et al. Characterization of micro-RNA in serum: A novel class of biomarkers for diagnosis of cancer and other diseases. Cell Research 2008, 18:997-1006.
22. Ng E.K., Chong W.W., Jin H., Lam E.K., Shin V.Y., Yu J., et al. Differential expression of micro-RNA in plasma of patients with colorectal cancer a potential marker for colorectal cancer screening. Gut 2009, 58:1375-1381.
23. Huang Z., Huang D., Ni S., Peng Z., Sheng W., Du X. Plasma micro-RNA are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 2010, 127:118-126.
24. Pu X.X., Huang G.L., Guo H.Q., Guo C.C., Li H., Ye S., et al. Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression. J Gastroenterol Hepatol 2010, 25:1674-1680.
25. Kanaan Z., Roberts H., Eichenberger M.R., Billeter A., Ocheretner G., Pan J., et al. A plasma microRNA panel for detection of colorectal adenomas: A step toward more precise screening for colorectal cancer. Ann Surg 2013, 258:400-408.
26. Cheng H., Zhang L., Cogdell D.E., Zheng H., Schetter A.J., Nykter M., et al. Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis. PLoS One 2011, 6:e17745.
27. Wang L.G., Gu J. Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metástasis. Cancer Epidemiol 2012, 36:e61-e67.
28. Menéndez P., Villarejo P., Padilla D., Menéndez J.M., Rodriguez Montes J.A. Diagnostic and prognostic significance of serum micro-RNA in colorectal cancer. J Surg Oncol 2013, 107:217-220.